BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27103308)

  • 1. Simultaneous hyperthermia-chemotherapy with controlled drug delivery using single-drug nanoparticles.
    Sato I; Umemura M; Mitsudo K; Fukumura H; Kim JH; Hoshino Y; Nakashima H; Kioi M; Nakakaji R; Sato M; Fujita T; Yokoyama U; Okumura S; Oshiro H; Eguchi H; Tohnai I; Ishikawa Y
    Sci Rep; 2016 Apr; 6():24629. PubMed ID: 27103308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous hyperthermia-chemotherapy effect by arterial injection of Fe(Salen) for femur tumor.
    Umemura M; Islam MR; Fukumura H; Sato I; Kawabata Y; Matsuo K; Nakakaji R; Nagasako A; Ohtake M; Takayuki F; Yokoyama U; Nakayama T; Eguchi H; Ishikawa Y
    Cancer Sci; 2019 Jan; 110(1):356-365. PubMed ID: 30375142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthermia and chemotherapy using Fe(Salen) nanoparticles might impact glioblastoma treatment.
    Ohtake M; Umemura M; Sato I; Akimoto T; Oda K; Nagasako A; Kim JH; Fujita T; Yokoyama U; Nakayama T; Hoshino Y; Ishiba M; Tokura S; Hara M; Muramoto T; Yamada S; Masuda T; Aoki I; Takemura Y; Murata H; Eguchi H; Kawahara N; Ishikawa Y
    Sci Rep; 2017 Feb; 7():42783. PubMed ID: 28218292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A magnetic anti-cancer compound for magnet-guided delivery and magnetic resonance imaging.
    Eguchi H; Umemura M; Kurotani R; Fukumura H; Sato I; Kim JH; Hoshino Y; Lee J; Amemiya N; Sato M; Hirata K; Singh DJ; Masuda T; Yamamoto M; Urano T; Yoshida K; Tanigaki K; Yamamoto M; Sato M; Inoue S; Aoki I; Ishikawa Y
    Sci Rep; 2015 Mar; 5():9194. PubMed ID: 25779357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
    Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
    Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthermia generated by magnetic nanoparticles for effective treatment of disseminated peritoneal cancer in an orthotopic nude-mouse model.
    Matsumi Y; Kagawa T; Yano S; Tazawa H; Shigeyasu K; Takeda S; Ohara T; Aono H; Hoffman RM; Fujiwara T; Kishimoto H
    Cell Cycle; 2021 Jun; 20(12):1122-1133. PubMed ID: 34110969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermia generated with ferucarbotran (Resovist®) in an alternating magnetic field enhances cisplatin-induced apoptosis of cultured human oral cancer cells.
    Sato I; Umemura M; Mitsudo K; Kioi M; Nakashima H; Iwai T; Feng X; Oda K; Miyajima A; Makino A; Iwai M; Fujita T; Yokoyama U; Okumura S; Sato M; Eguchi H; Tohnai I; Ishikawa Y
    J Physiol Sci; 2014 May; 64(3):177-83. PubMed ID: 24619404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The iron chelating agent, deferoxamine detoxifies Fe(Salen)-induced cytotoxicity.
    Umemura M; Kim JH; Aoyama H; Hoshino Y; Fukumura H; Nakakaji R; Sato I; Ohtake M; Akimoto T; Narikawa M; Tanaka R; Fujita T; Yokoyama U; Taguri M; Okumura S; Sato M; Eguchi H; Ishikawa Y
    J Pharmacol Sci; 2017 Aug; 134(4):203-210. PubMed ID: 28779994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.
    Li FR; Yan WH; Guo YH; Qi H; Zhou HX
    Int J Hyperthermia; 2009 Aug; 25(5):383-91. PubMed ID: 19391033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study.
    Balivada S; Rachakatla RS; Wang H; Samarakoon TN; Dani RK; Pyle M; Kroh FO; Walker B; Leaym X; Koper OB; Tamura M; Chikan V; Bossmann SH; Troyer DL
    BMC Cancer; 2010 Mar; 10():119. PubMed ID: 20350328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple Therapy of HER2
    Zolata H; Afarideh H; Davani FA
    Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro anti-cancer efficacy of multi-functionalized magnetite nanoparticles combining alternating magnetic hyperthermia in glioblastoma cancer cells.
    Minaei SE; Khoei S; Khoee S; Vafashoar F; Mahabadi VP
    Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():575-587. PubMed ID: 31029351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia.
    Babincov M; Altanerov V; Altaner C; Bergemann C; Babinec P
    IEEE Trans Nanobioscience; 2008 Mar; 7(1):15-9. PubMed ID: 18334449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles.
    Kalber TL; Ordidge KL; Southern P; Loebinger MR; Kyrtatos PG; Pankhurst QA; Lythgoe MF; Janes SM
    Int J Nanomedicine; 2016; 11():1973-83. PubMed ID: 27274229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An implantable smart magnetic nanofiber device for endoscopic hyperthermia treatment and tumor-triggered controlled drug release.
    Sasikala ARK; Unnithan AR; Yun YH; Park CH; Kim CS
    Acta Biomater; 2016 Feb; 31():122-133. PubMed ID: 26687978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of oral cancer using magnetized paclitaxel.
    Nakakaji R; Umemura M; Mitsudo K; Kim JH; Hoshino Y; Sato I; Masuda T; Yamamoto M; Kioi M; Koizumi T; Fujita T; Yokoyama U; Iida M; Sato M; Sato H; Murofushi S; Shibata S; Aoki I; Eguchi H; Tohnai I; Ishikawa Y
    Oncotarget; 2018 Mar; 9(21):15591-15605. PubMed ID: 29643995
    [No Abstract]   [Full Text] [Related]  

  • 17. Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells in vitro via hyperthermia.
    Zhang J; Dewilde AH; Chinn P; Foreman A; Barry S; Kanne D; Braunhut SJ
    Int J Hyperthermia; 2011; 27(7):682-97. PubMed ID: 21992561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An implantable smart hyperthermia nanofiber with switchable, controlled and sustained drug release: Possible application in prevention of cancer local recurrence.
    Samadzadeh S; Babazadeh M; Zarghami N; Pilehvar-Soltanahmadi Y; Mousazadeh H
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111384. PubMed ID: 33254991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro investigation on the magnetic thermochemotherapy mediated by magnetic nanoparticles combined with methotrexate for breast cancer treatment.
    Zhao L; Huo M; Liu J; Yao Z; Li D; Zhao Z; Tang J
    J Nanosci Nanotechnol; 2013 Feb; 13(2):741-5. PubMed ID: 23646507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
    Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
    Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.